Results 1 to 10 of about 349,270 (146)

Causal attribution to cervical cancer [PDF]

open access: yes, 2016
This study aimed to examine the causal attribution for cervical cancer for women with and without the disease. Seventy-eight (78) users from the public healthcare system participated, which were divided into: a clinical group (CG) of women with cervical ...
Armiliato, María Julia   +3 more
core   +2 more sources

Algoritmos de derivación y confirmación diagnóstica de citología cervical atípica: desafíos para la actualización [PDF]

open access: yes, 2012
Indexación: ScieloEl Programa Nacional de Pesquisa y Control del Cáncer Cervicouterino de Chile ha contribuido al descenso sostenido de la mortalidad por cáncer de cuello uterino.
Arcos G., Estela   +4 more
core   +3 more sources

Visual techniques for cervical cancer screening in Colombia

open access: yesBiomédica: revista del Instituto Nacional de Salud, 2019
Introduction: Direct visual inspection for cervical cancer screening remains controversial, whereas colposcopy-biopsy is considered the gold standard for diagnosis of preneoplastic cervical lesions.
Óscar Gamboa   +5 more
doaj   +1 more source

Knowledge and utilization of screening for cervical cancer among female in Ethiopia: a systemic review and meta-analysis [PDF]

open access: yesWorld Cancer Research Journal, 2021
Objective: The aim of this systemic review and meta-analysis was to verify that whether knowledge about screening for cervical cancer related with usage of screening for cervical cancer among female in Ethiopia.
T. Kaleab   +3 more
doaj   +1 more source

MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma [PDF]

open access: yes, 2018
Background The high incidence and mortality of lung tumours is a major health problem. Therefore, the identification both of biomarkers predicting efficacy for therapies in use and of novel efficacious therapeutic agents is crucial to increase patient ...
Carnero Moya, Amancio   +5 more
core   +1 more source

Presencia de lesiones preinvasoras e invasoras de cérvix, relación con el virus papiloma humano y factores epidemiológicos en Mérida, Venezuela

open access: yesQhaliKay, 2018
Las lesiones de cérvix se han asociado a infección por Virus Papiloma Humano (VPH). 300 mujeres mayores de quince años que acudieron al Hospital Universitario de Los Andes (HULA), fueron estudiadas para identificar lesiones, detectar y tipificar VPH, y ...
Luis Eduardo Téllez Gil   +5 more
doaj   +1 more source

Factores psicosociales en cáncer cervical

open access: yesCiencia y Sociedad, 1986
Este texto analiza el cáncer en los últimos años. Según la American Cancer Society, en América aproximadamente 76 millones de personas están expuestas a padecer de cáncer para los próximos años.
Francisco Monegro Peña   +1 more
doaj   +1 more source

Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition)

open access: yesXiehe Yixue Zazhi
Prophylactic human papilloma virus (HPV) vaccination is an effective strategy to prevent HPV infection and reduce the incidence of HPV-related diseases.Current clinical trials and real-world studies globally have demonstrated that prophylactic HPV ...
Society of Gynecologic Oncology, Chinese Medical Association   +6 more
doaj   +1 more source

Sobrevida en pacientes con cáncer de cervix

open access: yesActa Médica Costarricense, 2005
Objetivo: Estimar la probabilidad acumulada de sobrevida a cinco años, de una cohorte de pacientes diagnosticadas con cáncer de cervix durante 1999. Metodología: Para el análisis de la información se utilizaron distribuciones de frecuencia con valores ...
Adolfo Ortiz-Barboza   +1 more
doaj   +2 more sources

Tamizaje del cáncer cervical

open access: yesSalud Pública de México
Objetivo. Estimar las prevalencias de uso de las pruebas del Papanicolaou (Pap) y del virus del papiloma humano (VPH) antes y después del inicio de la pandemia por SARS-CoV-2. Material y métodos.
Leith Soledad León-Maldonado   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy